At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 80 enrolled
Drug / intervention
dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon) +3 moredrug
Likely dose
dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Two Part Bioequivalence Study to Compare Two Fixed Dose Combination Tablets of Dapagliflozin/Metformin XR 5/500 mg (Part 1) and 10/1000 mg (Part 2) Manufactured at Two Different Plants in Healthy Subjects Under Fasting and Fed Conditions
In Brief
A Phase 1 clinical trial evaluating dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon), dapagliflozin/metformin XR 5/500 mg reference drug (Humacao), and 2 other interventions for Bioequivalence and 2 related conditions. Completed, enrolled 80 participants across 1 site.
Detailed Summary
This is a bioequivalence study to compare 2 fixed-dose combination tablets of dapagliflozin/metformin XR manufactured at 2 different plants in healthy subjects under fasting and fed conditions
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedDec 2015
Primary CompletionApr 2016
TodayJul 2026
First PostedDec 22, 2015
Enrollment StartDec 21, 2015
Primary CompletionApr 7, 2016
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.5 years ago
Interventions
dapagliflozin/metformin XR 5/500 mg test drug (Mount Vernon)drug
single fixed-combination dose tablets
dapagliflozin/metformin XR 5/500 mg reference drug (Humacao)drug
single fixed-dose combination tablets
dapagliflozin/metformin XR 10/1000 mg test drug (Mount Vernon)drug
single fixed-dose combination tablets
dapagliflozin/metformin XR 10/1000 mg reference drug (Humacao)drug
single fixed-dose combination tablets